Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans

Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans

Abstract Background To address the US opioid epidemic, there is an urgent clinical need to provide persons with opioid use disorder (OUD) with effective medication treatments for OUD (MOUD). Formulations of sublingual buprenorphine/naloxone (SL-BUP/NLX) are considered the standard of care for OUD in...

Full description

Bibliographic Details
Main Authors: Ismene Petrakis, Sandra A. Springer, Cynthia Davis, Elizabeth Ralevski, Lucy Gu, Robert Lew, John Hermos, Melynn Nuite, Adam J. Gordon, Thomas R. Kosten, Edward V. Nunes, Robert Rosenheck, Andrew J. Saxon, Robert Swift, Alexa Goldberg, Robert Ringer, Ryan Ferguson
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid use disorder
Buprenorphine
Comparative effectiveness trial
Veterans
Injectable
Online Access:https://doi.org/10.1186/s13722-022-00286-6

Internet

https://doi.org/10.1186/s13722-022-00286-6

Similar Items